Korro Bio, Inc.

US$14.75As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:KRROHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (29.89%)
Div yield —
ROE (113.26%)
Biotechnology
Beta (5Y) 2.07
PE TTM —
TSR TTM (63.95%)
Mkt cap US$202.5M
ROIC (34.78%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
17.77%
61.85%
Hold 9|10|6|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.27
0.28
0.29
0.30
14.32%
8.94%
9.05%
11.17%
Revenue$M
22.11
21.84
22.86
23.98
(1.96%)
(2.09%)
4.27%
12.59%
Peers (US$202.5M)
Cap (US$)
PE
203.6M
—
Capital
TTM
5Y
10Y
Leveragex
2.504
0.187
0.201
EBIT/Intx
1.092
0.081
0.078
Own earn%
(38.49)
152.80
159.88
Sh yield%
29.87
20.38
20.37
Owners
Insiders/Inst%
8.89
87.43
Short interest%
3.08
SBC / revenue%
3.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
0–3
$1 testx
0.3
Incr. ROIC%
4